Feud surfaces between drugmakers, wholesalers over survival

Published: 2013-07-16 06:57:00

Updated: 2013-07-16 06:57:00

Tensions are high between pharmaceutical firms and wholesalers as drug companies have begun looking to make fundamental changes to their business strategies amid gloomy outer circumstances igniting the biggest crisis in years in Korea’s pharmaceutical industry.

Heaping further pressure is the ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK